Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In the phase 2 NEJM trial, between 4% and 10% of people taking retatrutide reported feeling unusually tired, compared to just 4% in the placebo group
Tirzepatide targets both GLP-1 and GIP receptors to reduce your appetite and slow down digestion
If the liver is working hard to process both drugs, there could be an increased risk of liver strain, especially in those with existing liver conditions
Clinical trials have shown that Ozempic provides cardiovascular benefits that reduce the risk of cardiovascular events such as stroke and heart attack in patients with type 2 diabetes What is the difference between Ozempic and Mounjaro
Healthcare systems are more focused on newer therapeutic approaches that not only control blood glucose but also target linked comorbidities
